文献速递妇产影像儿科影像US

早孕期颈项透明层增厚胎儿的结局:系统评价与Meta分析

Outcome of fetuses with early increased nuchal translucency: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-06-16

本系统评价与Meta分析纳入5项研究共401例头臀长小于45 mm且颈项透明层增厚的胎儿,其中3项研究269例进入Meta分析。早孕期颈项透明层增厚胎儿复合不良妊娠结局发生率为42.0%(95%CI 18.5-67.6%),染色体或基因异常为40.2%(95%CI 12.8-71.5%),结构异常为5.9%(95%CI 3.4-9.1%),围产期丢失为9.7%(95%CI 6.4-13.5%)。

要点

  • 早孕期颈项透明层增厚胎儿复合不良妊娠结局发生率为42.0%(95%CI 18.5-67.6%)。
  • 11-14周复查时增厚消退者不良结局发生率19.4%,持续增厚者为64.2%。
  • 颈项透明层2.5-3.4 mm、3.5-4.4 mm和≥4.5 mm者不良结局发生率分别为31.9%、50.4%和70.2%。

核心结论

  • 早孕期测量的颈项透明层增厚与不良妊娠结局、染色体异常、基因异常、结构异常及围产期丢失风险增加相关,即使其在11-14周复查时消退也是如此。

研究设计与样本

  • 系统评价与Meta分析,检索MEDLINE、EMBASE和Cochrane数据库从建库至2024年8月,纳入5项研究共401例头臀长小于45 mm且颈项透明层增厚的胎儿,其中3项研究269例进入随机效应Meta分析。

诊断标准与关键数值

  • 复合不良妊娠结局(染色体、基因或结构异常或围产期丢失)在早孕期颈项透明层增厚胎儿中发生率为42.0%(95%CI 18.5-67.6%)。
  • 染色体或基因异常(产前或产后评估)发生率为40.2%(95%CI 12.8-71.5%)。
  • 超声发现结构异常发生率为5.9%(95%CI 3.4-9.1%),围产期丢失发生率为9.7%(95%CI 6.4-13.5%)。
  • 11-14周复查时颈项透明层增厚消退者占48.8%(95%CI 30.6-67.1%),持续增厚者占51.2%(95%CI 32.9-69.4%)。
  • 颈项透明层2.5-3.4 mm、3.5-4.4 mm和≥4.5 mm者不良妊娠结局发生率分别为31.9%(95%CI 14.4-52.6%)、50.4%(95%CI 30.1-70.7%)和70.2%(95%CI 32.0-94.9%)。

临床应用与阅片要点

  • 早孕期颈项透明层增厚胎儿复合不良妊娠结局在持续增厚者为64.2%(95%CI 51.8-75.6%),在消退者为19.4%(95%CI 8.8-33.0%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Nuchal translucency (NT) has been the mainstay of the first-trimester screening assessment for fetal aneuploidies. Although NT is typically measured between 11 and 14 weeks' gestation when fetal crown-rump length (CRL) is between 45 and 85 mm, recent studies suggest that fetuses with increased NT measured in the early first trimester of pregnancy are also at high risk of aneuploidy, genetic disorders or adverse pregnancy outcomes. The aim of this systematic review was to report the outcomes of fetuses with early increased NT before 11 weeks' gestation.

METHODS: MEDLINE, EMBASE and Cochrane databases were searched from inception to August 2024. The inclusion criteria were studies reporting the outcome of fetuses with increased NT, defined according to an absolute cut-off or percentile in the original publication, and a CRL < 45 mm. The primary outcome was a composite score of adverse pregnancy outcome, including the presence of either chromosomal, genetic or structural anomalies, or perinatal loss. The secondary outcomes explored were: resolution of increased NT at the 11-14-week scan; chromosomal anomaly; copy-number variant detected on chromosomal microarray; single-gene disorder detected on next-generation sequencing; structural anomaly; perinatal loss, defined as the occurrence of miscarriage or fetal loss; and termination of pregnancy. All outcomes were explored in the overall population of fetuses with early increased NT, according to the resolution or persistence of increased NT and according to different NT thickness (2.5-3.4 mm, 3.5-4.4 mm and ≥ 4.5 mm). Random effects meta-analysis of proportions was used to combine the data and results were reported as pooled proportions with 95% CI.

RESULTS: Five studies (401 fetuses with CRL < 45 mm presenting with increased NT) were included in the systematic review and three of these (269 fetuses) were included in the meta-analysis. Composite adverse pregnancy outcome complicated 42.0% (95% CI, 18.5-67.6%) of pregnancies presenting with early increased NT. Chromosomal or genetic anomaly at either pre- or postnatal assessment was reported in 40.2% (95% CI, 12.8-71.5%) of cases. Structural anomaly was identified on ultrasound in 5.9% (95% CI, 3.4-9.1%) of fetuses with early increased NT, and perinatal loss occurred in 9.7% (95% CI, 6.4-13.5%) of cases. Of the fetuses presenting with increased NT in the early first trimester of pregnancy, 48.8% (95% CI, 30.6-67.1%) showed resolution of the increased NT at the 11-14-week scan, and the increased NT persisted in 51.2% (95% CI, 32.9-69.4%). Composite adverse pregnancy outcome occurred in 64.2% (95% CI, 51.8-75.6%) of fetuses in which increased NT was persistent at the 11-14-week scan and in 19.4% (95% CI, 8.8-33.0%) of those in which the increased NT resolved. Finally, when considering different cut-offs of NT thickness, adverse pregnancy outcome occurred in 31.9% (95% CI, 14.4-52.6%) of fetuses with NT between 2.5 and 3.4 mm, 50.4% (95% CI, 30.1-70.7%) of those with NT between 3.5 and 4.4 mm and 70.2% (95% CI, 32.0-94.9%) of those with NT ≥ 4.5 mm.

CONCLUSION: Increased NT measured in the early first trimester of pregnancy is associated with an increased risk of adverse pregnancy outcome, chromosomal, genetic and structural anomalies, and perinatal loss, even in case of its resolution at the time of the 11-14-week scan. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Matarrelli B, Khalil A, Bernassola M, et al. Outcome of fetuses with early increased nuchal translucency: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2025. PMID: 40519157. doi:10.1002/uog.29260

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。